Cytek Biosciences, Inc.
NASDAQ:CTKB
2.48 (USD) • At close May 21, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||||
| Current Assets: | |||||||||||||||||||
| Cash & Cash Equivalents
| 95.299 | 98.716 | 162.272 | 177.918 | 169.141 | 167.63 | 163.629 | 131.544 | 129.476 | 296.601 | 341.523 | 349.894 | 362.506 | 364.618 | 376.771 | 159.846 | 168.584 | 165.231 | -30.122 |
| Short Term Investments
| 170.314 | 179.145 | 115.505 | 99.323 | 101.298 | 95.111 | 124.392 | 167.294 | 169.519 | 44.548 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60.244 |
| Cash and Short Term Investments
| 265.613 | 277.861 | 277.777 | 277.241 | 270.439 | 262.741 | 288.021 | 298.838 | 298.995 | 341.149 | 341.523 | 349.894 | 362.506 | 364.618 | 376.771 | 159.846 | 168.584 | 165.231 | 30.122 |
| Net Receivables
| 55.029 | 60.588 | 52.634 | 44.752 | 50.372 | 56.12 | 55.402 | 52.099 | 43.1 | 50.875 | 40.008 | 37.183 | 32.002 | 29.76 | 29.45 | 24.029 | 15.513 | 16.99 | 0 |
| Inventory
| 45.347 | 43.893 | 46.8 | 50.07 | 54.742 | 60.877 | 66.875 | 65.731 | 69.502 | 48.154 | 49.369 | 45.345 | 37.982 | 32.171 | 27.511 | 26.655 | 26.218 | 23.018 | 0 |
| Other Current Assets
| 14.512 | 14.104 | 12.98 | 12.051 | 13.094 | 12.653 | 11.458 | 8.153 | 16.786 | 13.842 | 12.959 | 10.848 | 6.622 | 5.311 | 6.094 | 6.408 | 2.222 | 3.383 | 0 |
| Total Current Assets
| 380.501 | 396.446 | 390.191 | 384.084 | 388.647 | 392.06 | 422.315 | 424.821 | 425.622 | 454.02 | 443.859 | 443.27 | 439.112 | 432.052 | 439.826 | 216.938 | 212.537 | 208.622 | 30.122 |
| Non-Current Assets: | |||||||||||||||||||
| Property, Plant & Equipment, Net
| 27.703 | 28.13 | 28.632 | 27.442 | 28.196 | 29.258 | 29.118 | 28.011 | 28.736 | 27.565 | 22.26 | 20.975 | 20.343 | 5.851 | 4.982 | 3.895 | 2.476 | 2.14 | 0 |
| Goodwill
| 16.678 | 16.663 | 16.183 | 16.183 | 16.183 | 16.183 | 16.457 | 19.143 | 19.043 | 10.144 | 10.144 | 10.144 | 10.144 | 10.144 | 0.476 | 0.476 | 0.476 | 0.476 | 0 |
| Intangible Assets
| 19.431 | 20.128 | 20.492 | 21.42 | 22.252 | 23.084 | 24.292 | 23.683 | 24.764 | 4.331 | 4.485 | 3.859 | 4.328 | 4.739 | 0.361 | 0.333 | 0.274 | 0.274 | 0 |
| Goodwill and Intangible Assets
| 36.109 | 36.791 | 36.675 | 37.603 | 38.435 | 39.267 | 40.749 | 42.826 | 43.807 | 14.475 | 14.629 | 14.003 | 14.472 | 14.883 | 0.837 | 0.809 | 0.75 | 0.75 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 0 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 33.709 | 33.374 | 30.778 | 29.676 | 32.708 | 33.699 | 24.08 | 26.387 | 23.404 | 20.459 | 13.988 | 11.689 | 10.688 | 9.249 | 7.378 | 7.378 | 7.378 | 7.378 | 0 |
| Other Non-Current Assets
| 4.574 | 4.759 | 4.95 | 3.32 | 2.481 | 1.785 | 1.568 | 1.409 | 1.406 | 2.957 | 2.959 | 2.88 | 1.264 | 1.665 | 1.297 | 1.259 | 1.123 | 1.089 | -30.122 |
| Total Non-Current Assets
| 102.095 | 103.054 | 101.035 | 99.641 | 103.42 | 105.609 | 97.115 | 100.233 | 98.953 | 65.456 | 55.436 | 49.547 | 46.767 | 31.648 | 14.494 | 13.341 | 11.727 | 11.357 | -30.122 |
| Total Assets
| 482.596 | 499.5 | 491.226 | 483.725 | 492.067 | 497.669 | 519.43 | 525.054 | 524.575 | 519.476 | 499.295 | 492.817 | 485.879 | 463.7 | 454.32 | 230.279 | 224.264 | 219.979 | 0 |
| Liabilities & Equity: | |||||||||||||||||||
| Current Liabilities: | |||||||||||||||||||
| Account Payables
| 6.247 | 5.529 | 5.389 | 3.191 | 3.725 | 3.032 | 4.711 | 3.082 | 5.28 | 4.805 | 5.64 | 6.749 | 5.971 | 3.034 | 3.927 | 3.324 | 3.361 | 2.944 | 0 |
| Short Term Debt
| 0 | 8.414 | 0 | 12.309 | 4.218 | 14.328 | 12.893 | 3.492 | 3.585 | 3.511 | 1.413 | 2.529 | 2.214 | 0 | 0 | 0 | 2.772 | 2.772 | 0 |
| Tax Payables
| 0 | 3.559 | 1.738 | 0.358 | 0.72 | 1.297 | 2.213 | 2.166 | 1.975 | 1.667 | 1.149 | 1.291 | 4.062 | 3.879 | 1.142 | 0.953 | 0.968 | 1.034 | 0 |
| Deferred Revenue
| 27.706 | 25.492 | 25.365 | 23.968 | 23.009 | 22.695 | 23.047 | 22.15 | 18.104 | 14.541 | 13.122 | 9.991 | 13.418 | 7.081 | 5.885 | 4.668 | 3.522 | 4.289 | 0 |
| Other Current Liabilities
| 27.491 | 33.083 | 30.305 | 22.455 | 46.903 | 26.758 | 25.843 | 44.851 | 27.573 | 24.516 | 33.292 | 21.79 | 30.556 | 18.169 | 24.945 | 23.888 | 17.141 | 19.786 | 0 |
| Total Current Liabilities
| 67.691 | 67.663 | 62.797 | 52.379 | 55.566 | 56.226 | 58.693 | 53.591 | 56.517 | 49.04 | 41.494 | 42.35 | 42.803 | 32.16 | 29.839 | 28.165 | 27.764 | 26.536 | 0 |
| Non-Current Liabilities: | |||||||||||||||||||
| Long Term Debt
| 7.448 | 8.602 | 8.992 | 17.556 | 10.174 | 20.606 | 11.875 | 12.715 | 13.674 | 14.583 | 14.326 | 12.316 | 12.684 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 16.098 | 14.787 | 14.064 | 15.164 | 15.132 | 14.958 | 16.054 | 13.012 | 13.124 | 10.407 | 11.02 | 7.199 | 9.79 | 7.741 | 6.317 | 5.361 | 3.456 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 8.113 | 8.697 | 3.212 | 0 | 0 | 0 | 0 | 13.988 | 0 | 0 | 9.173 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 27.834 | 18.952 | 19.187 | 10.603 | 18.549 | 9.429 | 18.38 | 18.515 | 17.912 | 17.183 | 16.559 | 16.002 | 15.751 | 14.949 | 13.37 | 12.463 | 205.896 | 206.015 | 0 |
| Total Non-Current Liabilities
| 35.282 | 36.1 | 42.966 | 42.223 | 43.887 | 48.379 | 45.213 | 47.284 | 44.598 | 44.89 | 41.292 | 39.338 | 35.634 | 24.739 | 21.111 | 213.099 | 211.257 | 209.471 | 0 |
| Total Liabilities
| 102.973 | 103.763 | 105.763 | 94.602 | 99.453 | 104.605 | 103.906 | 100.875 | 101.115 | 93.93 | 82.786 | 81.688 | 78.437 | 56.899 | 50.95 | 241.264 | 239.021 | 236.007 | 0 |
| Equity: | |||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 499.295 | 492.817 | 485.879 | 0 | 454.32 | 194.319 | 194.319 | 194.319 | 74.653 |
| Common Stock
| 0.128 | 0.129 | 0.13 | 0.132 | 0.131 | 0.131 | 0.136 | 0.136 | 0.136 | 0.135 | 0.135 | 0.135 | 0.134 | 0.126 | 0.125 | 0.024 | 0.024 | 0.023 | 0 |
| Retained Earnings
| -46.601 | -35.199 | -44.84 | -45.781 | -35.347 | -29.178 | -34.681 | -28.225 | -23.837 | -17.03 | -20.559 | -22.225 | -21.627 | -18.19 | -18.24 | -19.835 | -22.505 | -22.607 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -0.609 | 0.016 | 0.101 | -0.195 | -1.554 | -1.275 | -1.579 | -1.759 | -0.587 | -0.697 | -0.53 | 0.228 | 0.911 | 0.897 | 0.57 | 0.536 | 0.267 | 0.065 | -41.701 |
| Other Total Stockholders Equity
| 426.705 | 430.791 | 430.072 | 434.967 | 429.384 | 423.386 | 451.648 | 454.027 | 447.748 | 442.887 | 437.401 | 432.889 | 427.818 | 423.625 | 420.6 | -186.344 | -194.319 | -194.319 | 0 |
| Total Shareholders Equity
| 379.623 | 395.737 | 385.463 | 389.123 | 392.614 | 393.064 | 415.524 | 424.179 | 423.46 | 425.295 | 416.447 | 411.027 | 407.236 | 406.458 | 403.055 | -11.3 | -15.072 | -16.028 | 32.952 |
| Total Equity
| 0 | 395.737 | 385.463 | 389.123 | 392.614 | 393.064 | 415.524 | 424.179 | 423.46 | 425.546 | 416.509 | 411.129 | 407.442 | 406.801 | 403.37 | -10.985 | -14.757 | -16.028 | 32.952 |
| Total Liabilities & Shareholders Equity
| 482.596 | 499.5 | 491.226 | 483.725 | 492.067 | 497.669 | 519.43 | 525.054 | 524.575 | 519.476 | 499.295 | 492.817 | 485.879 | 463.7 | 454.32 | 230.279 | 224.264 | 219.979 | 32.952 |